Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention

Kye Taek Ahn,Seok-Woo Seong,Ung-Lim Choi,Seon-Ah Jin,Jun Hyung Kim,Jae Hwan Lee,Si Wan Choi,Myung Ho Jeong,Shung Chull Chae,Young-Jo Kim,Chong-Jin Kim,Hyo-Soo Kim,Myeong Chan Cho,Hyeon-Cheol Gwon,Jin-Ok Jeong,In Whan Seong

Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention

2019

Kye Taek Ahn
Seok-Woo Seong
Ung-Lim Choi
Seon-Ah Jin
Jun Hyung Kim
Jae Hwan Lee
Si Wan Choi
Myung Ho Jeong
Shung Chull Chae
Young-Jo Kim
Chong-Jin Kim
Hyo-Soo Kim
Myeong Chan Cho
Hyeon-Cheol Gwon
Jin-Ok Jeong
In Whan Seong

AbstractAlthough the new oral P2Y12 inhibitors, prasugrel/ticagrelor have shown greater efficacy than clopidogrel in patients with the acute coronary syndrome, but they have not shown better efficacy in Korean patients. So we evaluated the efficacy of the prasugrel/ticagrelor in patients with myocar

Keywords:

Percutaneous coronary intervention
Physical therapy
Diabetes mellitus
Clopidogrel
Type 2 diabetes
Medicine
Myocardial infarction
Ticagrelor
Prasugrel
Internal medicine
Cardiology
Acute coronary syndrome
P2Y12

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations